1. Home
  2. ATHE vs MXC Comparison

ATHE vs MXC Comparison

Compare ATHE & MXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATHE
  • MXC
  • Stock Information
  • Founded
  • ATHE 1997
  • MXC 1972
  • Country
  • ATHE Australia
  • MXC United States
  • Employees
  • ATHE N/A
  • MXC N/A
  • Industry
  • ATHE Biotechnology: Pharmaceutical Preparations
  • MXC Oil & Gas Production
  • Sector
  • ATHE Health Care
  • MXC Energy
  • Exchange
  • ATHE Nasdaq
  • MXC Nasdaq
  • Market Cap
  • ATHE 21.4M
  • MXC 23.5M
  • IPO Year
  • ATHE N/A
  • MXC N/A
  • Fundamental
  • Price
  • ATHE $4.75
  • MXC $12.09
  • Analyst Decision
  • ATHE Strong Buy
  • MXC
  • Analyst Count
  • ATHE 2
  • MXC 0
  • Target Price
  • ATHE $8.00
  • MXC N/A
  • AVG Volume (30 Days)
  • ATHE 1.3M
  • MXC 19.5K
  • Earning Date
  • ATHE 02-15-2025
  • MXC 02-14-2025
  • Dividend Yield
  • ATHE N/A
  • MXC 0.83%
  • EPS Growth
  • ATHE N/A
  • MXC N/A
  • EPS
  • ATHE N/A
  • MXC 0.57
  • Revenue
  • ATHE $2,681,669.00
  • MXC $6,926,917.00
  • Revenue This Year
  • ATHE N/A
  • MXC N/A
  • Revenue Next Year
  • ATHE N/A
  • MXC N/A
  • P/E Ratio
  • ATHE N/A
  • MXC $21.25
  • Revenue Growth
  • ATHE 2.63
  • MXC N/A
  • 52 Week Low
  • ATHE $1.00
  • MXC $9.41
  • 52 Week High
  • ATHE $5.87
  • MXC $16.52
  • Technical
  • Relative Strength Index (RSI)
  • ATHE 75.45
  • MXC 51.51
  • Support Level
  • ATHE $2.76
  • MXC $11.50
  • Resistance Level
  • ATHE $5.14
  • MXC $12.14
  • Average True Range (ATR)
  • ATHE 0.42
  • MXC 0.62
  • MACD
  • ATHE 0.15
  • MXC -0.06
  • Stochastic Oscillator
  • ATHE 71.14
  • MXC 35.12

About ATHE Alterity Therapeutics Limited

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.

About MXC Mexco Energy Corporation

Mexco Energy Corporation is an independent oil and gas company. It is engaged in the exploration, development, and production of natural gas and crude oil properties located in the United States. The company carried out its operation in the Permian Basin of West Texas. It is focusing on two primary areas, the Delaware Basin located in the Western portion of the Permian Basin including Lea and Eddy Counties, New Mexico and Loving County, Texas, and the Midland Basin located in the Eastern portion of the Permian Basin including Reagan, Upton, Midland, Martin, Howard, and Glasscock Counties, Texas. The company generates revenue from Oil sales, Natural gas sales, oil and gas royalty interests.

Share on Social Networks: